+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Continuous Bioprocessing Market by Product Type, Process Stage, Technology, End User, Scale of Production, Bioreactor Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5012940
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The continuous bioprocessing market is experiencing rapid transformation, as industry leaders seek efficient, agile, and sustainable solutions for biological product manufacturing. Senior decision-makers now face a dynamic landscape shaped by technological innovations, evolving regulations, and a heightened focus on quality and scalability.

Market Snapshot: Continuous Bioprocessing Market Growth & Outlook

The continuous bioprocessing market grew from USD 282.42 million in 2024 to USD 343.95 million in 2025. It is expected to maintain strong momentum at a CAGR of 21.40%, with revenues projected to reach USD 904.20 million by 2030. This significant expansion reflects increasing adoption across therapeutic areas and manufacturing stages, fueled by the demand for streamlined production and enhanced product consistency across global regions.

Scope & Segmentation of the Continuous Bioprocessing Market

  • Product Types: Cell therapies (including Car-T and stem cell), gene therapies (non-viral and viral vector), monoclonal antibodies, recombinant proteins (enzymes, growth factors, insulin), and vaccines (conventional and mRNA types).
  • Process Stages: Downstream (continuous chromatography, extraction, filtration) and upstream bioprocessing (cell culture, perfusion culture).
  • Technologies: Continuous chromatography (expanded bed adsorption, simulated moving bed), continuous filtration (microfiltration, ultrafiltration), perfusion systems (ATF, spin filter, tangential flow), and single use systems (disposable bags, modular platforms, tubing assemblies).
  • End Users: Biotechnology companies (large and small), CDMOs of varying scales, large and mid-tier pharmaceutical companies, and research institutes.
  • Scale of Production: Commercial, laboratory (including reactors as small as under 50L to 200L), and pilot scale facilities of various capacities.
  • Bioreactor Types: Single use bioreactors (disposable bags, modular systems) and stainless steel bioreactors (airlift, stirred tank reactors).
  • Regional Breakdown: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (spanning key Western, Eastern, and Gulf markets), and Asia-Pacific (China, India, Japan, Australia, South Korea, and more).
  • Company Coverage: The report details notable developments and strategies among leading players such as Thermo Fisher Scientific, Danaher Corporation, Merck KGaA, Sartorius AG, Lonza Group AG, FUJIFILM Diosynth Biotechnologies, Repligen Corporation, Novasep Holding SAS, Applikon Biotechnology B.V., and Parker Hannifin Corporation.

Key Takeaways for Senior Decision-Makers

  • The adoption of continuous bioprocessing is accelerating as firms seek to improve productivity, achieve process consistency, and support diverse therapeutic pipelines such as cell and gene therapies.
  • Technological advancements in perfusion culture, single use systems, and continuous chromatography are central to enabling flexible, modular operations, allowing manufacturers to respond to shifting market demands and regulatory requirements.
  • Digitalization, process analytics, and real-time monitoring are now driving process intensification and supporting sustainability goals through reduced resource consumption.
  • Segmented adoption patterns reveal that biotechnology and pharmaceutical firms each prioritize specific workflows and technologies aligned to their product portfolios and operational capacities.
  • Regional strategies are vital; mature markets adopt harmonized standards and pilot programs, while emerging regions focus on infrastructure, local partnerships, and talent development.
  • Success depends on integrating digital process control, strategic alliances, and iterative process improvement throughout commercialization and scale-up phases.

Tariff Impact on the Continuous Bioprocessing Market

Forthcoming U.S. tariffs in 2025 are set to raise costs across upstream and downstream equipment segments, with implications for sourcing strategies and price competitiveness. As import duties increase on key equipment and consumables, manufacturers are re-evaluating supply chain partnerships, considering domestic and nearshore alternatives, and focusing on procurement integration to maintain margin integrity and operational momentum in continuous processing initiatives.

Methodology & Data Sources

This market intelligence leverages primary interviews with senior executives, engineers, and regulatory specialists, complemented by secondary research across peer-reviewed literature, regulatory filings, and patent databases. Multi-stage validation and advisory review ensure comprehensive coverage and robust data integrity.

Why This Report Matters

  • Actionable insights help organizations identify new investment opportunities, benchmark operational transformations, and shape supply chain strategies aligned to shifting regulations and tariffs.
  • In-depth segmentation and regional analysis equip stakeholders with the knowledge required to customize technology adoption and partnership models for competitive advantage.
  • This report supports evidence-based decision-making by combining qualitative and quantitative analysis rooted in industry expertise and rigorous research standards.

Conclusion

Continuous bioprocessing is redefining biomanufacturing with superior agility, efficiency, and adaptability. Organizations leveraging these insights will be best positioned for sustainable growth and long-term leadership as the market continues to evolve.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Continuous Bioprocessing Market, by Product Type
8.1. Introduction
8.2. Cell Therapies
8.2.1. Car-T Therapies
8.2.2. Stem Cell Therapies
8.3. Gene Therapies
8.3.1. Non Viral
8.3.2. Viral Vector
8.4. Monoclonal Antibodies
8.5. Recombinant Proteins
8.5.1. Enzymes
8.5.2. Growth Factors
8.5.3. Insulin
8.6. Vaccines
8.6.1. Conventional Vaccines
8.6.2. Mrna Vaccines
9. Continuous Bioprocessing Market, by Process Stage
9.1. Introduction
9.2. Downstream Bioprocessing
9.2.1. Continuous Chromatography
9.2.2. Continuous Extraction
9.2.3. Continuous Filtration
9.3. Upstream Bioprocessing
9.3.1. Continuous Cell Culture
9.3.2. Perfusion Culture
10. Continuous Bioprocessing Market, by Technology
10.1. Introduction
10.2. Continuous Chromatography
10.2.1. Expanded Bed Adsorption
10.2.2. Simulated Moving Bed
10.3. Continuous Filtration
10.3.1. Microfiltration
10.3.2. Ultrafiltration
10.4. Perfusion Systems
10.4.1. Atf Perfusion
10.4.2. Spin Filter Perfusion
10.4.3. Tangential Flow Perfusion
10.5. Single Use Systems
10.5.1. Disposable Bags
10.5.2. Modular Single Use Systems
10.5.3. Tubing Assemblies
11. Continuous Bioprocessing Market, by End User
11.1. Introduction
11.2. Biotechnology Companies
11.2.1. Large Biotech Firms
11.2.2. Small Biotech Firms
11.3. Cdmos
11.3.1. Large Cdmos
11.3.2. Small Cdmos
11.4. Pharmaceutical Companies
11.4.1. Big Pharma Companies
11.4.2. Mid Tier Pharma
11.5. Research Institutes
12. Continuous Bioprocessing Market, by Scale of Production
12.1. Introduction
12.2. Commercial Scale
12.2.1. Large Commercial Plants
12.2.2. Medium Commercial Plants
12.2.3. Small Commercial Facilities
12.3. Laboratory Scale
12.3.1. Lab Reactors 50-200L
12.3.2. Lab Reactors < 50L
12.4. Pilot Scale
12.4.1. Pilot Plants 200-500L
12.4.2. Pilot Plants < 200L
12.4.3. Pilot Plants >500L
13. Continuous Bioprocessing Market, by Bioreactor Type
13.1. Introduction
13.2. Single Use Bioreactors
13.2.1. Disposable Bags
13.2.2. Modular Single Use Systems
13.3. Stainless Steel Bioreactors
13.3.1. Airlift Bioreactors
13.3.2. Stirred Tank Reactors
14. Americas Continuous Bioprocessing Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Continuous Bioprocessing Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Continuous Bioprocessing Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Thermo Fisher Scientific Inc.
17.3.2. Danaher Corporation
17.3.3. Merck KGaA
17.3.4. Sartorius AG
17.3.5. Lonza Group AG
17.3.6. FUJIFILM Diosynth Biotechnologies
17.3.7. Repligen Corporation
17.3.8. Novasep Holding SAS
17.3.9. Applikon Biotechnology B.V.
17.3.10. Parker Hannifin Corporation
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. CONTINUOUS BIOPROCESSING MARKET MULTI-CURRENCY
FIGURE 2. CONTINUOUS BIOPROCESSING MARKET MULTI-LANGUAGE
FIGURE 3. CONTINUOUS BIOPROCESSING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS STAGE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF PRODUCTION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF PRODUCTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTOR TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTOR TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. CONTINUOUS BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. CONTINUOUS BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CONTINUOUS BIOPROCESSING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CAR-T THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY STEM CELL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY GENE THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY NON VIRAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONVENTIONAL VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MRNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY DOWNSTREAM BIOPROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS EXTRACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS FILTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY DOWNSTREAM BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY UPSTREAM BIOPROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PERFUSION CULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY UPSTREAM BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY EXPANDED BED ADSORPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SIMULATED MOVING BED, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS FILTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MICROFILTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY ULTRAFILTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS FILTRATION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PERFUSION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY ATF PERFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SPIN FILTER PERFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY TANGENTIAL FLOW PERFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SINGLE USE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY DISPOSABLE BAGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MODULAR SINGLE USE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY TUBING ASSEMBLIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SINGLE USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY LARGE BIOTECH FIRMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SMALL BIOTECH FIRMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CDMOS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY LARGE CDMOS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SMALL CDMOS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CDMOS, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIG PHARMA COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MID TIER PHARMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF PRODUCTION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL SCALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY LARGE COMMERCIAL PLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MEDIUM COMMERCIAL PLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SMALL COMMERCIAL FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL SCALE, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY LABORATORY SCALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY LAB REACTORS 50-200L, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY LAB REACTORS < 50L, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY LABORATORY SCALE, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT SCALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT PLANTS 200-500L, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT PLANTS < 200L, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT PLANTS >500L, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT SCALE, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTOR TYPE, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SINGLE USE BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY DISPOSABLE BAGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MODULAR SINGLE USE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SINGLE USE BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY STAINLESS STEEL BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY AIRLIFT BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY STIRRED TANK REACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY STAINLESS STEEL BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY DOWNSTREAM BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY UPSTREAM BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS FILTRATION, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY SINGLE USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY CDMOS, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF PRODUCTION, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL SCALE, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY LABORATORY SCALE, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT SCALE, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTOR TYPE, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY SINGLE USE BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY STAINLESS STEEL BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY DOWNSTREAM BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY UPSTREAM BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS FILTRATION, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY SINGLE USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY CDMOS, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF PRODUCTION, 2018-2030 (USD MILLION)
TABLE 135. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL SCALE, 2018-2030 (USD MILLION)
TABLE 136. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY LABORATORY SCALE, 2018-2030 (USD MILLION)
TABLE 137. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT SCALE, 2018-2030 (USD MILLION)
TABLE 138. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTOR TYPE, 2018-2030 (USD MILLION)
TABLE 139. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY SINGLE USE BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 140. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY STAINLESS STEEL BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 141. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 142. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 143. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 144. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 145. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 146. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 147. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 148. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY DOWNSTREAM BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 149. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY UPSTREAM BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 150. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 152. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS FILTRATION, 2018-2030 (USD MILLION)
TABLE 153. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 154. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SINGLE USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 155. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 157. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY CDMOS, 2018-2030 (USD MILLION)
TABLE 158. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 159. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF PRODUCTION, 2018-2030 (USD MILLION)
TABLE 160. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL SCALE, 2018-2030 (USD MILLION)
TABLE 161. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY LABORATORY SCALE, 2018-2030 (USD MILLION)
TABLE 162. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT SCALE, 2018-2030 (USD MILLION)
TABLE 163. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTOR TYPE, 2018-2030 (USD MILLION)
TABLE 164. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SINGLE USE BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 165. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY STAINLESS STEEL BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 166. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 167. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 168. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 169. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 170. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 171. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 172. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY DOWNSTREAM BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 173. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY UPSTREAM BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 174. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 175. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 176. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS FILTRATION, 2018-2030 (USD MILLION)
TABLE 177. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 178. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY SINGLE USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 179. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 181. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY CDMOS, 2018-2030 (USD MILLION)
TABLE 182. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 183. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF PRODUCTION, 2018-2030 (USD MILLION)
TABLE 184. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL SCALE, 2018-2030 (USD MILLION)
TABLE 185. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY LABORATORY SCALE, 2018-2030 (USD MILLION)
TABLE 186. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT SCALE, 2018-2030 (USD MILLION)
TABLE 187. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTOR TYPE, 2018-2030 (USD MILLION)
TABLE 188. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY SINGLE USE BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 189. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY STAINLESS STEEL BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 190. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 191. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 192. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 193. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 194. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 195. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 196. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY DOWNSTREAM BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 197. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY UPSTREAM BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 198. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 199. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 200. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS FILTRATION, 2018-2030 (USD MILLION)
TABLE 201. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 202. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SINGLE USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 203. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 205. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CDMOS, 2018-2030 (USD MILLION)
TABLE 206. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 207. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF PRODUCTION, 2018-2030 (USD MILLION)
TABLE 208. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL SCALE, 2018-2030 (USD MILLION)
TABLE 209. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY LABORATORY SCALE, 2018-2030 (USD MILLION)
TABLE 210. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT SCALE, 2018-2030 (USD MILLION)
TABLE 211. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTOR TYPE, 2018-2030 (USD MILLION)
TABLE 212. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SINGLE USE BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 213. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY STAINLESS STEEL BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 214. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 215. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 216. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 217. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 218. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 219. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 220. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY DOWNSTREAM BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 221. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY UPSTREAM BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 222. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 223. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 224. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS FILTRATION, 2018-2030 (USD MILLION)
TABLE 225. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 226. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SINGLE USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 227. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 229. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY CDMOS, 2018-2030 (USD MILLION)
TABLE 230. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 231. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF PRODUCTION, 2018-2030 (USD MILLION)
TABLE 232. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL SCALE, 2018-2030 (USD MILLION)
TABLE 233. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY LABORATORY SCALE, 2018-2030 (USD MILLION)
TABLE 234. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT SCALE, 2018-2030 (USD MILLION)
TABLE 235. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTOR TYPE, 2018-2030 (USD MILLION)
TABLE 236. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SINGLE USE BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 237. ARGENTINA CONTINUOUS BIOPROCESSING MARKET SIZE, BY STAINLESS STEEL BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY DOWNSTREAM BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY UPSTREAM BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS FILTRATION, 2018-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SINGLE USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY CDMOS, 2018-2030 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF PRODUCTION, 2018-2030 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL SCALE, 2018-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY LABORATORY SCALE, 2018-2030 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT SCALE, 2018-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTOR TYPE, 2018-2030 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SINGLE USE BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY STAINLESS STEEL BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 264. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 266. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 268. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY DOWNSTREAM BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 270. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY UPSTREAM BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 272. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS FILTRATION, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY SINGLE USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY CDMOS, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 280. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF PRODUCTION, 2018-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL SCALE, 2018-2030 (USD MILLION)
TABLE 282. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY LABORATORY SCALE, 2018-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT SCALE, 2018-2030 (USD MILLION)
TABLE 284. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTOR TYPE, 2018-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY SINGLE USE BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 286. UNITED KINGDOM CONTINUOUS BIOPROCESSING MARKET SIZE, BY STAINLESS STEEL BIOREACTORS, 2018-2030 (USD MILLION)
TABLE 287. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 288. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL THERAPIES, 2018-2030 (USD MILLION)
TABLE 289. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY GENE THERAPIES, 2018-2030 (USD MILLION)
TABLE 290. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 291. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 292. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS STAGE, 2018-2030 (USD MILLION)
TABLE 293. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY DOWNSTREAM BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 294. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY UPSTREAM BIOPROCESSING, 2018-2030 (USD MILLION)
TABLE 295. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 296. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 297. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS FILTRATION, 2018-2030 (USD MILLION)
TABLE 298. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PERFUSION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 299. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY SINGLE USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 300. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 302. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY CDMOS, 2018-2030 (USD MILLION)
TABLE 303. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 304. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF PRODUCTION, 2018-2030 (USD MILLION)
TABLE 305. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL SCALE, 2018-2030 (USD MILLION)
TABLE 306. GERMANY CONTINUOUS BIOPROCESSING MARKET SIZE, BY LABORATORY SCALE, 2018-2030 (USD MILLION)
TABLE 307. GERMANY CONTINUOUS BIOPROCESSING MARKET

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Continuous Bioprocessing market report include:
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Merck KGaA
  • Sartorius AG
  • Lonza Group AG
  • FUJIFILM Diosynth Biotechnologies
  • Repligen Corporation
  • Novasep Holding SAS
  • Applikon Biotechnology B.V.
  • Parker Hannifin Corporation

Table Information